ScanScor Hall of Fame: Past AI Winners

This table lists stocks reported on and flagged by ScanScor as favorable for any number of reasons, showing the gains following the alert. This study compares the AI-generated price targets against actual market highs. AI isn’t always right, but it is more than just most of the time. Stocks that achieved or exceeded their targets are listed here.
Ticker Report Date Sizzle Score Headline Report Price Target Price Max Price % Max Total Gain Days to Target
GRFX 2025-03-20 70 Graphex group shows strong momentum amidst sales decline $0.31 $0.46 $1.73 463.17% 0 (same day)
GATE 2025-03-24 60 Marblegate acquisition high insider confidence amid financial uncertainties $14.54 $16.00 $61.11 320.31% 0 (same day)
LXEH 2025-03-26 75 Strong stock performance clashes with negative financial indicators $12.80 $19.28 $50.08 291.25% 0 (same day)
IBO 2025-03-20 70 Impact biomedical shows mixed performance amid high investor interest $1.63 $2.50 $6.17 278.53% 1
GATE 2025-03-25 60 Marblegate acquisition soaring market performance amid financial uncertainty $17.99 $22.50 $61.11 239.70% 3
ABVE 2025-04-28 75 Soaring price amid weak fundamentals a closer look at abve $0.93 $1.39 $2.92 213.30% 1
MMA 2025-04-02 60 Company sees monthly gains amidst quarterly downtrend $0.92 $1.30 $2.88 212.91% 10
GDHG 2025-03-24 60 Golden heaven group sees spike in volume amidst sales decline $1.72 $2.25 $5.25 205.18% 1
ELPW 2025-04-15 72 Elong power surges amid speculation and short interest $2.18 $3.27 $6.43 194.95% 3
VVPR 2025-03-24 60 Vivopower shows promise amidst sales slump upward move likely $2.38 $4.40 $6.66 179.83% 3
GATE 2025-03-27 72 Impressive market performance amidst alarming financial health $21.88 $35.07 $61.11 179.31% 0 (same day)
TOI 2025-04-01 70 Oncology institute sees strong growth amidst concerns over high debt and negative returns $1.30 $1.89 $3.50 169.23% 30
LOCL 2025-04-02 65 Sales surge amid insider confidence but returns remain negative $2.25 $2.73 $5.75 155.46% 1
TOI 2025-03-24 85 Strong performance and sales growth propel oncology institutes upward trend $1.21 $1.61 $2.96 144.63% 30
TOI 2025-04-02 75 Oncology institute soars despite negative returns bolstered by insider confidence $1.48 $1.81 $3.50 136.49% 30
RGLS 2025-04-28 65 Regulus skyrockets despite financial turbulence speculative interest peaks $3.53 $5.26 $8.20 132.62% 3
LOCL 2025-04-03 65 Strong sales growth amid financial distress signals mixed outlook $2.54 $3.66 $5.75 126.38% 1
OCG 2025-03-27 70 Strong momentum amid financial concerns a balancing act $1.88 $2.67 $4.17 121.57% 1
UVIX 2025-04-03 65 Rising company scores high on performance low on revenue $47.60 $72.03 $105.18 120.97% 1
GDHG 2025-03-25 64 Golden heavens bullish trend amid concerning sales decline $2.38 $3.50 $5.25 120.55% 0 (same day)
CEP 2025-04-24 75 Unprecedented surge in cantor equity partners amid speculative trading $27.90 $41.63 $59.75 114.20% 10
RYET 2025-04-15 65 Ruanyun edai surges insider confidence high amidst sales decline $7.17 $8.00 $15.20 111.99% 1
TCRT 2025-04-02 60 Company shows promising growth despite negative financials $2.53 $3.24 $5.35 111.46% 1
AREN 2025-04-16 64 The arena sees price surge amid sales decline and high insider activity $2.46 $2.95 $5.00 103.25% 10
QSG 2025-03-31 92 High returns amid sales decline a paradoxical performance $4.07 $6.15 $7.96 95.55% 1
EPWK 2025-04-25 85 Epwk skyrockets analyzing the surge and future prospects $13.38 $19.07 $26.00 94.32% 10
FATN 2025-04-16 65 Fatpipes stable growth amid absent financial details $8.84 $10.35 $17.00 92.31% 1
UPXI 2025-04-24 65 Upexis stock soars amid speculative trading despite weak fundamentals $12.03 $16.52 $22.57 87.61% 1
PRTG 2025-04-17 65 Portage biotech rocketing stock amidst financial turbulence $8.49 $12.60 $15.82 86.34% 3
UVXY 2025-04-03 92 Robust performance and strong balance sheet predict upward momentum $28.58 $43.23 $53.21 86.18% 3
Page 1 of 3   Next »